Matribhumi Samachar English
Burlington, Ontario–(Newsfile Corp. – March 13, 2026) – Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC: MUSLF) (FSE: 93X) (“Promino” or the “Company”) announces that it intends to complete a non-brokered private placement for aggregate gross proceeds of up to $1,200,000 through the issuance of up to 40,000,000 units of the …
Read More »CSE Bulletin: Reinstatement – Promino Nutritional Sciences Inc. (MUSL)
Toronto, Ontario–(Newsfile Corp. – Le 2 décembre/December 2025) – Effective immediately, Promino Nutritional Sciences Inc. will be reinstated for trading. The Company has rectified the situation that gave rise to the suspension. _________________________________ Avec effet immédiat, Promino Nutritional Sciences Inc. sera réintégrée à la négociation. La Société a rectifié la …
Read More »Promino Resumes Trading and Achieves Record Sales Growth Through October 2025
Burlington, Ontario–(Newsfile Corp. – December 2, 2025) – Promino Nutritional Sciences Inc. (CSE: MUSL) (OTCID: MUSLF) (FSE: 93X) (“Promino” or the “Company”) is pleased to announce the resumption of trading on the Canadian Securities Exchange effective today. The trading halt, in effect since May 8, 2025, has been lifted following …
Read More »Promino Nutritional Sciences Inc. Announces that Promino(TM) Named Official Protein Drink of the Vegas Knight Hawks
Expanding U.S. sports presence as brand aligns with Las Vegas franchises Burlington, Ontario–(Newsfile Corp. – April 17, 2025) – Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC Pink: MUSLF) (FSE: 93X) (the “Company” or “Promino”), a Canadian leader in muscle health and functional performance beverages, is pleased to announce that its …
Read More »Promino Nutritional Sciences Inc. Launches Second Preclinical Study Targeting Reduction of Muscle Loss in Breast and Prostate Cancer Patients Undergoing Chemotherapy
Research to explore Promino’s patented amino acid blend in addressing treatment-related muscle wasting in two of the most prevalent cancers among women and menStudy led by Dr. Patrick Gunning, Professor of Medicinal Chemistry and Molecular Therapeutics, University of Toronto and University of Glasgow Burlington, Ontario–(Newsfile Corp. – April 14, 2025) …
Read More »Promino Nutritional Sciences Inc. Announces Private Placement Financing
Burlington, Ontario–(Newsfile Corp. – February 24, 2025) – Promino Nutritional Sciences Inc. (CSE: MUSL) (OTC Pink: MUSLF) (FSE: 93X) ( the “Company” or “Promino”) (www.drinkpromino.com) is pleased to announce it intends to conduct a private placement of units of the Company (“Units”) at a price of $0.05 per Unit for …
Read More »